An Advanced Antibody-Based Therapeutics Company

Immunomedics is committed to be a leading, innovative biopharmaceutical company, dedicated to improving patient's health and quality of life with novel antibody–based therapeutics for the treatment of cancer, autoimmune and other serious diseases. Our work is driven by scientific excellence and the highest standards, in a culture of integrity, pride and dedication. In doing so, we create value for our shareholders and a rewarding environment for our employees.